Beata Godlewska

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

uzay emir

University of Oxford

UNITED KINGDOM

View details

Catherine Harmer

Professor of Cognitive Neuroscience

University of Oxford

UNITED KINGDOM

View details

Orla Macdonald

University of Oxford

UNITED KINGDOM

View details

Diede Fennema

King’s College London

UNITED KINGDOM

View details

Ladislav Valkovič

University of Oxford

UNITED KINGDOM

View details

Stephen R. Williams

UNITED KINGDOM

View details

Belinda Lennox

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Beata Godlewska

Research Interests

Explore related searches

Contact this professor

Articles (9)

Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study

Negative bias in encoding and recall memory in depressed patients with inadequate response to antidepressant medication

Six-Week Supplementation with Creatine in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Magnetic Resonance Spectroscopy Feasibility Study at 3 Tesla

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication

Neural signatures of emotional biases predict clinical outcomes in difficult-to-treat depression

The Potential Use of Ebselen in Treatment-Resistant Depression

Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case–control study at 7 T

Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment

A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania

Collaborators (7)

uzay emir

Catherine Harmer

Orla Macdonald

Diede Fennema

Ladislav Valkovič

Stephen R. Williams

Belinda Lennox

Make your next move.